{ Banner Photo }

BRG White Paper Cited in Trump Administration's “American Patients First" Plan on Prescription Drug Prices

May 11, 2018

Aaron Vandervelde and Eleanor Blalock's white paper Measuring the Relative Size of the 340B Program: 2012-2017 was cited in the Trump Administration's American Patients First plan on prescription drug prices.

In the white paper, Mr. Vandervelde and Ms. Blalock write about estimates of 340B Drug Discount Program sales and annual US drug sales and the impact of the 340B program on the pharmaceuticals market.

Read the white paper.

Related Professionals